Nicoya launches cost-effective and flexible digital SPR solutions to support biologics discovery

March 05, 2024 08:00 AM EST | By EIN Presswire

Google News:

Nicoya launches cost-effective and flexible digital SPR solutions to support biologics discovery — Image source: EIN Presswire

Recent News

Stonegate Updates Coverage on Hooker Furniture Corporation (HOFT) Q1 F...

FluroTech Ltd. Announces Change in Directors

SEC Names Erik Hotmire as Chief External Affairs Officer and Director...

SEC Names Kurt Hohl as Chief Accountant

KITCHENER, ON, CANADA, March 5, 2024 /EINPresswire.com/ -- Nicoya Lifesciences Inc., a pioneering life sciences instrument company specializing in innovative biosensor technologies, is pleased to announce the launch of flexible software configuration packages for their flagship Alto™ Digital Surface Plasmon Resonance (Digital SPR™) system. These packages are designed to provide access to the innovative Alto system at a cost-effective price for scientists. The Alto systems accelerate the study of biomolecular interactions and screening for lead drug candidates across various stages of biologics discovery.

Acknowledging the continued challenging macroeconomic environment for many biotech companies, Nicoya^® unveiled its strategy to help companies and academic institutions advance their R&D initiatives by increasing the affordability of Alto. This milestone underscores Nicoya’s unwavering commitment to provide accessible research tools to the scientific community.

The new Alto configurations provide flexibility tailored to scientists’ specific research needs. Users can choose between two software options – the Nicosystem™ Pro and Nicosystem™ Essentials – and add additional software application modules as needed, enabling customization that meets the users’ budgets. Additionally, Alto’s main consumable – the Alto Cartridge™ – will now be offered at a lower price point to further drive down operating costs.

"With the introduction of these new software configurations, we aim to empower labs of all sizes to leverage the time-, sample- and cost-saving capabilities of digital SPR for their research needs,” said Sriram Kumaraswamy, PhD, Senior Vice President of Marketing & Product at Nicoya. “We are confident these enhancements will ease financial burdens and help companies in their pursuit of R&D initiatives in the coming years, making a positive impact on life sciences research.”

For more information about Nicoya and its digital SPR platforms, please visit nicoyalife.com.

Jessica Lin
Nicoya Lifescience
[email protected]
Visit us on social media:
Facebook
Twitter
LinkedIn
Instagram

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations, and video (Content) is a service of Kalkine Media Incorporated (“Kalkine Media, we or us”), Business Number: 720744275BC0001 and is available for personal and non-commercial use only. The advice given by Kalkine Media through its Content is general information only and it does not take into account the user’s personal investment objectives, financial situation and specific needs. Users should make their own enquiries about any investment and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media is not registered as an investment adviser in Canada under either the provincial or territorial Securities Acts. Some of the Content on this website may be sponsored/non-sponsored, as applicable, however, on the date of publication of any such Content, none of the employees and/or associates of Kalkine Media hold positions in any of the stocks covered by Kalkine Media through its Content. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content. Some of the images/music that may be used in the Content are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used in the Content unless stated otherwise. The images/music that may be used in the Content are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.

View All

News

Trending Topics

Related Articles

Sponsored Articles

1

2

3

4

5

Investing Ideas

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20